News
Post Doctoral Scientist post available at Boehringer - Research Beyond Borders working with the UK Cystic Fibrosis Gene Therapy Consortium
1 year ago The UK Cystic Fibrosis Gene Therapy Consortium, Boehringer Ingelheim, Imperial Innovations and Oxford BioMedica Announce New Partnership to Develop First-In-Class Gene Therapy for Cystic Fibrosis
1 year ago Flutterby Fundraisers to Sponsor Consortium Scientist
2 years ago New Publication - Gelinas et al 2017 - Media Supplements to Improve Lentiviral Vector Production Yields
2 years ago Gene Therapy Funding Update
2 years ago Consortium Student Live Facebook Interview from ASGCT
2 years ago
1 year ago The UK Cystic Fibrosis Gene Therapy Consortium, Boehringer Ingelheim, Imperial Innovations and Oxford BioMedica Announce New Partnership to Develop First-In-Class Gene Therapy for Cystic Fibrosis
1 year ago Flutterby Fundraisers to Sponsor Consortium Scientist
2 years ago New Publication - Gelinas et al 2017 - Media Supplements to Improve Lentiviral Vector Production Yields
2 years ago Gene Therapy Funding Update
2 years ago Consortium Student Live Facebook Interview from ASGCT
2 years ago
Prof Jane Davies Podcast with Lancet Respiratory Medicine
Thursday, August 11th 2016
August's issues of Lancet Respiratory Medicine is a special issue on Cystic Fibrosis.
Accompanying the issue is a podcast by our very own Prof Jane Davies. There are articles on personalized medicine in CF, classification of CF mutations and some latest data from ongoing studies with Orkambi.
You can download the podcast (mp3) here.
Prof Jane Davies's Publications.
An Introduction to our Multi-Dose Clinical Trial (2012): A number of our Edinburgh team discuss the clinical trial. More...
